Carregant...

Sleep Disordered Breathing in Infants with Prader-Willi Syndrome During the First 6 Weeks of Growth Hormone Therapy: A Pilot Study

BACKGROUND: Sleep-related breathing disorders are common in individuals with Prader-Willi syndrome (PWS). The US Food and Drug Administration approved the use of growth hormone in PWS in 2000. Many infants with PWS are being started on growth hormone therapy, but no data exist on the respiratory eff...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Miller, Jennifer L., Shuster, Jonathan, Theriaque, Douglas, Driscoll, Daniel J., Wagner, Mary
Format: Artigo
Idioma:Inglês
Publicat: American Academy of Sleep Medicine 2009
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2762717/
https://ncbi.nlm.nih.gov/pubmed/19961030
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!